Guo et al. showed that the overexpressed SLC7A11 in HCC is often associated with tumor progression as well as poor prognosis, whereas SLC7A11 suppression attenuated HCC cell proliferation [70]. Here, SLC7A11 is linked to hepatocellular carcinoma.